Aspect Biosystems gets $79M from Canadian government for diabetes cell therapy
Aspect Biosystems gets $79M from Canadian government for diabetes cell therapy
Aspect Biosystems gets $79M from Canadian government for diabetes cell therapy
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.